InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,235.48
(
-0.60%
)
US TECH 100
18,020.00
(
-1.30%
)
Dow Jones
38,111.48
(
-0.86%
)
Brent Oil
81.75
(
-0.24%
)
Bitcoin
68,307.83
(
-0.08%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: None

Friday, 02/15/2008 3:49:46 PM

Friday, February 15, 2008 3:49:46 PM

Post# of 92948
fwiw,

a new venture fund that will focus solely on stem cell and regenerative medicine companies
Gregory A. Bonfiglio is the Managing Partner of Proteus Venture Partners. Greg was an early investor in stem cell & regenerative medicine companies - his prior firm, Anthem Venture Partners, funded Advanced Cell Technology (ACTC.OB) in 2000, and Mr. Bonfiglio led the team that took the Company public in early 2005.

Proteus
http://www.proteusvp.com/about.htm
"The emergence of Regenerative Medicine as a driving force in healthcare represents an extraordinary investment opportunity. Proteus is a specialty life sciences fund focused exclusively on Regenerative Medicine."

Part of Advisory Board
Robert Lanza, Ph.D. (Vice President of Medical and Scientific Development, Advanced Cell Technology; SCNT, Cell Therapies and Differentiation; Authored numerous textbooks and peer reviewed articles on regenerative medicine)
http://www.proteusvp.com/board.htm


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up